{"id":2797,"date":"2007-02-09T15:48:08","date_gmt":"2007-02-09T14:48:08","guid":{"rendered":"https:\/\/www.rcts.fr\/uncategorized\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients"},"modified":"2020-04-07T16:16:20","modified_gmt":"2020-04-07T14:16:20","slug":"randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients","status":"publish","type":"post","link":"https:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/","title":{"rendered":"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study"},"content":{"rendered":"<table border=\"0\" width=\"538\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td class=\"xl70\" width=\"292\" height=\"85\">14th Conference on Retroviruses and Opportunistic Infections &#8211; Los Angeles, February 25-28, 2007 (abstract 503)<\/td>\n<td class=\"xl69\" width=\"246\">D. Rey, P. Chavanet, M.P. Schmitt, G. Hoizey, P. Meyer, G. Peytavin, B. Spire, B. Hoen, C. Allavena, M. Diemer, T. May, J.L. Schmit, M. Duong, V. Calvez, J.M. Lang<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>14th Conference on Retroviruses and Opportunistic Infections &#8211; Los Angeles, February 25-28, 2007 (abstract 503) D. Rey, P. Chavanet, M.P. Schmitt, G. Hoizey, P. Meyer, G. Peytavin, B. Spire, B. Hoen, C. Allavena, M. Diemer, T. May, J.L. Schmit, M. Duong, V. Calvez, J.M. Lang<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[],"class_list":["post-2797","post","type-post","status-publish","format-standard","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study - RCTs<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study - RCTs\" \/>\n<meta property=\"og:description\" content=\"14th Conference on Retroviruses and Opportunistic Infections &#8211; Los Angeles, February 25-28, 2007 (abstract 503) D. Rey, P. Chavanet, M.P. Schmitt, G. Hoizey, P. Meyer, G. Peytavin, B. Spire, B. Hoen, C. Allavena, M. Diemer, T. May, J.L. Schmit, M. Duong, V. Calvez, J.M. Lang\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"RCTs\" \/>\n<meta property=\"article:published_time\" content=\"2007-02-09T14:48:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-07T14:16:20+00:00\" \/>\n<meta name=\"author\" content=\"Didier Not\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Didier Not\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/\"},\"author\":{\"name\":\"Didier Not\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\"},\"headline\":\"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study\",\"datePublished\":\"2007-02-09T14:48:08+00:00\",\"dateModified\":\"2020-04-07T14:16:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/\"},\"wordCount\":76,\"commentCount\":0,\"publisher\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/\",\"name\":\"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study - RCTs\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#website\"},\"datePublished\":\"2007-02-09T14:48:08+00:00\",\"dateModified\":\"2020-04-07T14:16:20+00:00\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rcts.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#website\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/\",\"name\":\"RCTs\",\"description\":\"Description\",\"publisher\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/www.rcts.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#organization\",\"name\":\"RCTs\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"contentUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"width\":163,\"height\":47,\"caption\":\"RCTs\"},\"image\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\",\"name\":\"Didier Not\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"caption\":\"Didier Not\"},\"url\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/author\\\/dnorcts-fr\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study - RCTs","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/","og_locale":"en_US","og_type":"article","og_title":"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study - RCTs","og_description":"14th Conference on Retroviruses and Opportunistic Infections &#8211; Los Angeles, February 25-28, 2007 (abstract 503) D. Rey, P. Chavanet, M.P. Schmitt, G. Hoizey, P. Meyer, G. Peytavin, B. Spire, B. Hoen, C. Allavena, M. Diemer, T. May, J.L. Schmit, M. Duong, V. Calvez, J.M. Lang","og_url":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/","og_site_name":"RCTs","article_published_time":"2007-02-09T14:48:08+00:00","article_modified_time":"2020-04-07T14:16:20+00:00","author":"Didier Not","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Didier Not"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/#article","isPartOf":{"@id":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/"},"author":{"name":"Didier Not","@id":"http:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5"},"headline":"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study","datePublished":"2007-02-09T14:48:08+00:00","dateModified":"2020-04-07T14:16:20+00:00","mainEntityOfPage":{"@id":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/"},"wordCount":76,"commentCount":0,"publisher":{"@id":"http:\/\/www.rcts.fr\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/","url":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/","name":"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study - RCTs","isPartOf":{"@id":"http:\/\/www.rcts.fr\/#website"},"datePublished":"2007-02-09T14:48:08+00:00","dateModified":"2020-04-07T14:16:20+00:00","breadcrumb":{"@id":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/www.rcts.fr\/en\/randomised-trial-comparing-tenofovir-df-lamivudine-and-nevirapine-once-daily-with-nevirapine-and-a-fixed-dose-of-zidovudine-and-lamivudine-twice-daily-in-antiretroviral-naive-hiv-infected-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rcts.fr\/"},{"@type":"ListItem","position":2,"name":"Randomised trial comparing Tenofovir DF, Lamivudine and Nevirapine once daily, with Nevirapine and a fixed dose of Zidovudine and Lamivudine twice daily, in antiretroviral na\u00efve HIV-infected patients: DAUFIN study"}]},{"@type":"WebSite","@id":"http:\/\/www.rcts.fr\/#website","url":"http:\/\/www.rcts.fr\/","name":"RCTs","description":"Description","publisher":{"@id":"http:\/\/www.rcts.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/www.rcts.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"http:\/\/www.rcts.fr\/#organization","name":"RCTs","url":"http:\/\/www.rcts.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/www.rcts.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","contentUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","width":163,"height":47,"caption":"RCTs"},"image":{"@id":"http:\/\/www.rcts.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"http:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5","name":"Didier Not","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","caption":"Didier Not"},"url":"https:\/\/www.rcts.fr\/en\/author\/dnorcts-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/comments?post=2797"}],"version-history":[{"count":1,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2797\/revisions"}],"predecessor-version":[{"id":2798,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2797\/revisions\/2798"}],"wp:attachment":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/media?parent=2797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/categories?post=2797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}